These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6113031)

  • 21. Effects of calcium channel blockers on stimulation-induced changes in transmitter release at the frog neuromuscular junction.
    Zengel JE; Lee DT; Sosa MA; Mosier DR
    Synapse; 1993 Dec; 15(4):251-62. PubMed ID: 7908759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of quantal transmitter release by the polycationic ligand cationized ferritin.
    Publicover SJ
    Exp Brain Res; 1985; 59(3):629-32. PubMed ID: 2863166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1984 Jan; 228(1):121-7. PubMed ID: 6607337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1982 Jul; 222(1):87-93. PubMed ID: 6123595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the presynaptic and post-synaptic actions of pentobarbitone and phenobarbitone in the neuromuscular junction of the frog.
    Proctor WR; Weakly JN
    J Physiol; 1976 Jun; 258(1):257-68. PubMed ID: 181566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mediator secretion in the nerve-muscle synapse in the frog following long-term effect of calcium-free solutions].
    Zefirov AL; Mukhamedzianov RD; Minlebaev MG; Cheranov SIu; Abdrakhmanov MM; Grigor'ev PN
    Ross Fiziol Zh Im I M Sechenova; 2002 Feb; 88(2):191-204. PubMed ID: 11938649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of trifluoperazine and promethazine on the release of transmitter quanta at the mouse neuromuscular junction.
    Nishimura M; Komatsu R; Taquahashi Y; Shimizu Y; Satoh E
    J Peripher Nerv Syst; 1998; 3(2):111-5. PubMed ID: 10959244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity increases quantal size at the frog neuromuscular junction.
    Van der Kloot W; Van der Kloot TE
    Experientia; 1985 Jan; 41(1):47-8. PubMed ID: 3871401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the time course of evoked quantal release at the frog neuromuscular junction using end-plate current latencies.
    Baldo GJ; Cohen IS; Van der Kloot W
    J Physiol; 1986 May; 374():503-13. PubMed ID: 3489094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of quantal releases during end-plate currents at the frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1988 Aug; 402():605-26. PubMed ID: 2853224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in miniature end-plate potentials after brief nervous stimulation at the frog neuromuscular junction.
    Doherty P; Hawgood BJ; Smith IC
    J Physiol; 1984 Nov; 356():349-58. PubMed ID: 6335174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission.
    Alderdice MT; Trommer BA
    J Pharmacol Exp Ther; 1980 Oct; 215(1):92-6. PubMed ID: 6256522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative description of stimulation-induced changes in transmitter release at the frog neuromuscular junction.
    Magleby KL; Zengel JE
    J Gen Physiol; 1982 Oct; 80(4):613-38. PubMed ID: 6128373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmitter release during repetitive stimulation: selective changes produced by Sr2+ and Ba2+.
    Zengel JE; Magleby KL
    Science; 1977 Jul; 197(4298):67-9. PubMed ID: 17160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
    Grinnell AD; Pawson PA
    J Physiol; 1989 Nov; 418():397-410. PubMed ID: 2576068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual effects of theophylline on spontaneous transmitter release from frog motor nerve terminals.
    Barry SR
    J Neurosci; 1988 Dec; 8(12):4427-33. PubMed ID: 2904489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lanthanum as a surrogate for calcium in transmitter release at mouse motor nerve terminals.
    Curtis MJ; Quastel DM; Saint DA
    J Physiol; 1986 Apr; 373():243-60. PubMed ID: 2875177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.